SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 7, 2024, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2024 and to highlight recent corporate progress. Conference Call & Webcast Details Date:Wednesday, August 7th, 2024Time:4:30 p.m. ETParticipant Link:Registration – Click HereWebcast Link:https://edge.media-server.com/mmc/p/jojadok2/ Participants may acce ...

LAWRENCEVILLE, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced that it has entered into definitive securities purchase agreements for a registered direct offering of its common stock priced at-the-market under Nasdaq rules. In a concurrent private placement and also pursuant to the securities purchase agreements, the Company has agreed to issue to the investors unregistered warrants to ...

Fibromyalgia is a "diagnosable condition" in people suffering from Long COVID according to NASEM1 Diagnosing fibromyalgia in Long COVID patients is expected to expand the potential addressable market for Tonmya relative to pre-COVID-19 pandemic estimates2 Tonmya is a potential new first-line non-opioid analgesic under development for the management of fibromyalgia with Fast Track designation: NDA submission target is second half of 2024, with potential for FDA approval in 2025 CHATHAM, N.J., July 31, 2024 ( ...

Trading Symbols:    TSX/NYSE AMERICAN: SVM VANCOUVER, BC, July 31, 2024 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) is pleased to announce that it will proceed to close the acquisition of Adventus Mining Corporation ("Adventus") pursuant to the arrangement agreement (the "Arrangement Agreement") under which the Company agreed to acquire all of the issued and outstanding common shares of Adventus by way of a plan of arrangement (the "Transaction") as ...

Homes prioritize sustainability, healthy living, energy savings and connected living to make life at home easier and more comfortable DALLAS, July 31, 2024 /PRNewswire/ -- Landsea Homes Corporation (Nasdaq: LSEA) ("Landsea Homes" or the "Company"), a publicly traded residential homebuilder, announced today the launch of its highly acclaimed and industry leading High Performance Home program to all currently selling and future planned new home communities in the Dallas-Fort Worth market. Landsea Homes expand ...

文章核心观点 - 公司发布了ARK: Survival Evolved的新扩展包Genesis Part 2,这将为Nintendo Switch平台上的玩家带来更加沉浸式的游戏体验和新的挑战 [1][2][3] - 这一新扩展包的推出将有助于推动ARK系列在Nintendo平台上的持续增长和玩家参与度 [4] 公司概况 - Snail是一家领先的全球独立游戏开发商和发行商,拥有优质的游戏作品组合,覆盖主机、PC和移动设备等多个平台 [5] 新闻发布相关 - 公司表示致力于支持和拓展ARK系列,确保玩家能够获得最新最棒的ARK世界冒险内容 [3] - 公司将继续致力于满足社区不断变化的需求,并拥抱各个平台,让ARK系列尽可能为更多玩家所接触 [4]

LOS ANGELES, July 31, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The GotStocks Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The GotStocks Podcast puts the small-cap sector in the limelight with in-depth interviews featuring executives responsible for guiding gems that ...

DELAWARE, Ohio, July 31, 2024 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE:GEF, GEF.B))), a global leader in industrial packaging products and services, announced today it will report the company's 2024 third quarter financial results after the market closes on Wednesday, August 28, 2024. A conference call will be held on Thursday, August 29, 2024, at 8:30 a.m. ET to discuss the quarter results. Greif will provide conference call slides in combination with its third quarter earnings press release. The conference c ...

Media Release Entered into third and most important clinical trial collaboration and supply agreement to date with MSD to evaluate eftilagimod alfa (efti) in combination with KEYTRUDA® (pembrolizumab) and chemotherapy for first-line non-small cell lung cancer in a pivotal Phase III trialContinuing positive clinical data reported from efti: Positive results from TACTI-003 Phase IIb trial in first-line head and neck squamous cell carcinoma with efti in combination with KEYTRUDA®Encouraging efficacy and safety ...

文章核心观点 - authID与Kaiasoft.com签署了一项转售协议,将authID的生物识别身份验证解决方案引入Kaiasoft.com的客户群 [2][3] - authID的生物识别身份验证解决方案可以帮助Kaiasoft.com的客户应对诸如钓鱼攻击、deepfake和被盗凭证等造成的身份欺骗和账户接管问题 [4][6] - authID的生物识别身份验证解决方案可以提供快速、无摩擦的用户体验,取代容易被破解的密码和知识问题验证 [5][6][7] 公司概况 - authID是一家提供创新生物识别身份验证解决方案的公司,在身份验证和认证领域具有领先地位 [8] - Kaiasoft.com是一家专注于开发SaaS应用程序的软件公司,在数字创新和帮助组织实现转型方面具有专业优势 [9] 合作背景 - Kaiasoft.com选择authID作为合作伙伴,是因为authID能够提供最高的身份准确性和最快的无摩擦用户体验 [3] - 通过与authID的合作,Kaiasoft.com将把其所有SaaS客户都迁移到authID的平台上,以提供更好的安全性、无缝的用户体验和更低的客户支持成本 [5] 合作目标 - 双方将共同努力,帮助客户加快良好的客户入职、验证年龄,并使用无缝的生物识别认证来保护重要交易,阻止由对抗性AI驱动的deepfake和账户接管诈骗 [5][6]